Researchers tracked data from more than 1,500 patients who underwent a successful TAVR procedure from 2016 to 2019. Researchers tracked data from more than 1,500 patients who underwent a successful TAVR procedure from 2016 to 2019. | |
|
The two-year rates of all-cause mortality or disabling stroke were 4.3% for TAVR patients and 6.3% for SAVR patients. The two-year rates of all-cause mortality or disabling stroke were 4.3% for TAVR patients and 6.3% for SAVR patients. | |
|
Researchers found that the procedure was associated with a high success rate and low mortality and stroke rates after 30 days. Researchers found that the procedure was associated with a high success rate and low mortality and stroke rates after 30 days. | |
|
The solution has still only been approved in the United States for investigational use. The solution has still only been approved in the United States for investigational use. | |
|
To build and validate their advanced AI model, researchers explored data from nearly 78,000 TAVR hospitalizations. To build and validate their advanced AI model, researchers explored data from nearly 78,000 TAVR hospitalizations. | |
|
The study’s authors developed and validated a new performance measure for TAVR care using data from more than 52,000 patients. They shared their full analysis ahead of print in Circulation. The study’s authors developed and validated a new performance measure for TAVR care using data from more than 52,000 patients. They shared their full analysis ahead of print in Circulation. | |
|
When patients with post-TAVR infective endocarditis have a stroke, their risk of in-hospital mortality and all-cause mortality after one year both skyrocket. When patients with post-TAVR infective endocarditis have a stroke, their risk of in-hospital mortality and all-cause mortality after one year both skyrocket. | |
|
Researchers in Germany explored data from more than 400 TAVR patients, sharing their findings in the Journal of the American College of Cardiology. Researchers in Germany explored data from more than 400 TAVR patients, sharing their findings in the Journal of the American College of Cardiology. | |
|
The findings, published in the Journal of the American College of Cardiology, focused on data from the VIVID registry. The findings, published in the Journal of the American College of Cardiology, focused on data from the VIVID registry. | |
|
Researchers presented 30-day data at the SCAI 2021 Scientific Sessions, highlighting the "excellent" outcomes and the importance of constantly working to improve patient care. Researchers presented 30-day data at the SCAI 2021 Scientific Sessions, highlighting the "excellent" outcomes and the importance of constantly working to improve patient care. | |
|